Background: EGFR is a receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. It activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. Defects in EGFR are associated with lung cancer (LNCR).
Immunogen: A synthetic peptide from the internal region of EGFR which includes the mutation of A839T, human origin.
Constituents: PBS (without Mg 2+ and Ca 2+ ), pH 7.4, 150 mM NaCl, 50% glycerol
Species Reactivity: Recognizes EGFR (A839T), but not wild type EGFR of vertebrates.
Storage Conditions: Store at -20°C. Avoid freeze / thaw cycles.
Western blot:
Western blot analysis of recombinant EGFR(A839T) and wildtype proteins. Purified His-tagged EGFR (A839T) protein (702-987) (Cat. #10221) and wild-type protein (702-987) (Cat. #10210) were blotted with anti- EGFR (A839T) mouse antibody (Cat. #26117).
Immunofluorescence of cells expressing EGFR proteins with anti-EGFR (A839T) antibody. HEK293T cells were transfected with pCDNA3-GFP-EGFR (WT) plasmid (left column) or pCDNA3-GFP-EGFR (A839T) plasmid (right column), then fixed and stained with anti- EGFR (A839T) monoclonal antibody (Cat. #26117).